CIPO Patents = 1

EPO Patents = 3

Trademarks = 2

Forward Citations = 0

Loading Chart...

2 inventors (with patents filed for the assignee):

Lynn Durham (7 out of 7 patents)

Jean-Marc Hyvelin (1 out of 2 patents)

Stéphane Baudouin (0 patent)

7 patents: Sort by Forward Citations

1. 12474327 - Metabolic profiling for the diagnosis of a subset of idiopathic autism spectrum disorder patients, ADS Phenotype 1 (2025-11-18),

2. 12435353 - Biomarker assay for use in monitoring autism (2025-10-07),

3. 11439627 - Pharmaceutical composition for the treatment of autism (2022-09-13),

4. 11364311 - Method of identifying ASD phenotype 1 patients (2022-06-21),

5. 11357871 - Challenge test for diagnosing subtypes of ASD (2022-06-14),

6. 11040117 - Treatment of a subtype of ASD (2021-06-22),

7. 10940140 - Pharmaceutical composition for the treatment of autism (2021-03-09),

Company Overview

Stalicla S.a. is a biotech company focused on developing precision medicine solutions for neurodevelopmental disorders. Through innovative AI technology and personalized therapies, Stalicla aims to improve the lives of individuals with conditions such as autism and rare genetic disorders.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

7 Patents

#51 in Geneva

#1,435 in Switzerland

Geneva, Switzerland

Stalicla S.a.

Forward Citations = 0

2 inventors:

Lynn Durham (7 out of 7 patents)

Jean-Marc Hyvelin (1 out of 2 patents)

Stéphane Baudouin (0 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Stalicla S.a.. Retrieved from https://idiyas.com/company/stalicla-s-a

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]